Allergy Medicine While Breastfeeding: A Safe-Use India Guide

• Non-sedating antihistamines (loratadine, cetirizine, levocetirizine, fexofenadine, desloratadine) are first-line and compatible with breastfeeding, with relative infant doses under 5 percent.
• Steroid nasal sprays (fluticasone, mometasone, budesonide) are arguably the safest powerful option for moderate-to-severe allergic rhinitis because almost none of the drug reaches your bloodstream or milk.
• Older sedating antihistamines (Avil/chlorpheniramine, Benadryl/diphenhydramine, Phenergan/promethazine) can make the baby drowsy and can reduce milk supply; fine for an occasional dose, not for daily use.
• Oral decongestants, especially pseudoephedrine, can cut milk supply by 20 to 30 percent from a single dose; avoid them, particularly in the early weeks.
• Stopping breastfeeding for routine allergy treatment is almost never required; if a medicine bothers the baby, switch the drug, not the feed.
• Read the label of every Indian combination cold-and-allergy tablet (Sinarest, D-Cold, Coldarin) and pick single-ingredient drugs you actually need.

Allergic rhinitis (hay fever) and other allergic conditions are very common in India. Epidemiological surveys suggest roughly 20 to 30 percent of urban Indian adults have allergic rhinitis, with similar rates of atopic dermatitis in children and rising food allergy in metro areas. The triggers are everywhere: high air pollution in Delhi, Mumbai, Bengaluru, Chennai, Kolkata and Hyderabad, especially in winter; seasonal pollens (tree pollen February to April in the north, grass pollen July to September, weed pollen October to November); monsoon mould; and a heavy indoor load of house dust mites in humid coastal cities, plus cockroach allergen and biomass cooking-fuel smoke in many homes. These same triggers can also make a baby sneeze, which is usually harmless reflex rather than allergy (why newborns sneeze so often).

For a breastfeeding mother, allergy creates three overlapping problems. The symptoms themselves disrupt feeding and sleep; there is a strong temptation to over-medicate from the chemist without guidance; and the fear of drugs passing into milk often leads to under-treatment or sudden weaning, which strips the baby of a major source of immune protection. Continued breastfeeding actually lowers a baby's allergy risk through immune programming and by avoiding early cow's-milk-protein exposure. The WHO, the American Academy of Pediatrics (AAP), the Academy of Breastfeeding Medicine (ABM) and the Indian Academy of Pediatrics all support continued breastfeeding alongside routine maternal allergy treatment.

How much of any drug reaches your baby depends on the same factors for allergy medicines as for any other: molecular size, how tightly the drug binds to your blood proteins, fat solubility, your peak blood level and the drug's half-life. The standard yardstick is the relative infant dose (RID), the percentage of your weight-adjusted dose the baby receives through milk. Under 10 percent is generally considered safe, 10 to 25 percent warrants caution, and over 25 percent usually means avoid. Most modern antihistamines have RIDs under 5 percent, nasal sprays barely register, and even the older sedating antihistamines mostly sit in the 1 to 5 percent range, where the concern is the drug's sedating effect rather than the raw dose.

The Indian pharmacy adds two real-world wrinkles. First, a huge share of over-the-counter products are combination tablets with three or four active ingredients, which makes assessment harder than for a single drug. Second, chemist advice is often a blanket "don't take anything while feeding" that is far more conservative than what the drug databases actually say. The lactation-friendly approach is to identify each active ingredient in a product, look each one up in LactMed or e-Lactancia (both free, with apps and websites), and pick the safest effective option for your specific symptoms.

The baby's age matters too. Newborns under 2 months clear drugs more slowly, so caution is a little higher; babies over 6 months on solids get a smaller share of nutrition from milk and are even less affected; by a year, when breastfeeding is supplementary, any single dose is negligible. This is why a drug that warrants caution for a 2-week-old can be perfectly fine for a 14-month-old.

Finally, untreated allergy has its own cost. A blocked nose that wrecks your sleep lowers milk supply more than almost any safe antihistamine does. Chronic mouth-breathing dries the throat and invites infection, allergic conjunctivitis worsens fatigue, and uncontrolled allergic asthma is genuinely dangerous and must be treated. The right balance is to treat symptoms properly with the safest effective drug, not to refuse everything over a milk-transfer worry the evidence does not support.

Modern second-generation H1 antihistamines are the cornerstone of allergy care while breastfeeding. They are non-sedating (or barely sedating) at standard doses, have low RIDs, are cheap, widely stocked, and effective for sneezing, runny nose, itchy eyes and skin itch. The five you will meet most in India are loratadine, cetirizine, levocetirizine, fexofenadine and desloratadine, and all are rated compatible with breastfeeding by LactMed, e-Lactancia, Hale's reference, the AAP and the ABM.

Loratadine (Alaspan, Lorfast, Loratin, Lorinol and many generics) is often called the best-studied non-sedating option for breastfeeding because of the volume of reassuring data. The RID is roughly 0.7 to 1.2 percent, among the lowest of any lactation drug. Standard dose is 10 mg once daily; it works within 1 to 3 hours and lasts 24 hours. No infant sedation has been reported at standard doses. A strip of ten costs around 30 to 80 rupees, and it also comes as a syrup and a fast-melt tablet.

Cetirizine (Alerid, Cetzine, Zyrtec, Okacet and generics) has an RID around 3 percent, still well within the safe range. Standard dose is 10 mg once daily, often at bedtime because about 1 in 10 people feel mildly drowsy on it. If you want a touch of drowsiness to help night-time itch, cetirizine at night is useful; if you need to drive or work sharp, loratadine may suit better. It is the workhorse for chronic hives, perennial rhinitis and general itch in India, at around 25 to 60 rupees a strip.

Levocetirizine (Levocet, Xyzal, 1-AL, Vozet) is the active half of cetirizine, so 5 mg once daily does the same job; some find it slightly less drowsy because the total dose is lower. RID and safety mirror cetirizine, around 40 to 100 rupees a strip.

Fexofenadine (Allegra, Alernex, Fexotic) has an RID under 1 percent and is essentially non-sedating in everyone, making it ideal for working mothers and anyone who drives. Standard dose is 120 mg once daily for rhinitis or 180 mg for chronic hives, around 50 to 150 rupees a strip. Take it with water, not fruit juice (grapefruit, orange and apple juice cut its absorption sharply).

Desloratadine (Aerius, Dazit) is the active metabolite of loratadine, 5 mg once daily, with a similarly low RID, around 70 to 200 rupees a strip. There is no need to switch from loratadine if it works for you, but desloratadine sometimes helps when loratadine feels not quite strong enough.

Bilastine (Blexten in some pharmacies) is newer, with very low brain penetration and almost no sedation; breastfeeding data is more limited but suggests low transfer. At 20 mg once daily and 150 to 300 rupees, it is a reasonable backup if the older options are not tolerated.

Practical guidance: pick one non-sedating antihistamine and use it consistently. Start low (loratadine 10 mg or levocetirizine 5 mg) and step up only if symptoms are not controlled. Many mothers need just one tablet a day during peak season (north India spring pollen, Diwali smog, monsoon mould) and stop in quiet spells. There is no tolerance or withdrawal, so you can start and stop freely. For year-round perennial rhinitis from dust mites or pet dander, daily use is safe throughout the breastfeeding journey, and there is no need to bring forward Weaning From Breastfeeding: When and How to Stop Gently on account of allergy medicine.

Intranasal corticosteroid sprays are arguably the single best choice for moderate-to-severe allergic rhinitis while breastfeeding, because they pair high effectiveness with essentially no milk-transfer concern. The drug is delivered straight onto the nasal lining; only a tiny fraction (typically under 1 percent for modern molecules) is absorbed into the blood, so the level in milk is negligible. LactMed and e-Lactancia rate these fully compatible with breastfeeding, and ARIA, BSACI and Indian allergy guidelines recommend them as first-line for moderate-to-severe symptoms.

Many Indian mothers assume that anything "sprayed" must be stronger and riskier than a tablet. For systemic absorption and milk transfer, the opposite is true: a steroid nasal spray is actually safer than an oral antihistamine. The word "steroid" also frightens people, but an intranasal corticosteroid is nothing like a high-dose oral steroid taken systemically.

Fluticasone (Flonase, Flixonase; the newer fluticasone furoate as Avamys, Veramyst) and mometasone (Nasonex, Momate-Nasal, Metaspray) are the most stocked in India. Standard dose is two sprays in each nostril once daily, dropping to one spray each nostril for maintenance once controlled. Effectiveness builds over 1 to 2 weeks of daily use, so this is a controller, not a rescue spray. A bottle of around 120 sprays lasts roughly a month and costs about 350 to 800 rupees. Good technique (aim toward the outer wall of the nostril, not the septum, and breathe in gently) prevents the occasional mild nosebleed or dryness.

Budesonide (Rhinocort, Budenase, Budez) has slightly more systemic absorption than fluticasone or mometasone but is still firmly within the safe range, and it is especially well-studied because the inhaled form is widely used for asthma in pregnancy and breastfeeding. Beclomethasone (Beclate Nasal) and triamcinolone (Nasacort) are older but equally compatible, typically 250 to 700 rupees a bottle.

Use the spray every day, even on mild days, because the controller effect fades within a few days of stopping. If symptoms are not fully controlled, combine the spray with a non-sedating antihistamine tablet; together they work better than either alone and remain fully safe. Add a plain saline nasal spray (Nasivion Saline, Otrivin Saline, generic; 100 to 200 rupees) before the steroid spray to clear mucus and improve penetration. Do not confuse these controllers with oxymetazoline or xylometazoline decongestant sprays (adult Nasivion, adult Otrivin), which must not be used beyond 3 to 5 days because of rebound congestion. If you have wrestled with a blocked nose since pregnancy, the same logic applied earlier in pregnancy rhinitis and nasal congestion.

First-generation sedating antihistamines (chlorpheniramine, diphenhydramine, hydroxyzine, promethazine, brompheniramine) are cheap, everywhere, and packed into many Indian combination cold tablets and cough syrups. They work, but they carry two specific breastfeeding concerns the modern drugs do not: a small risk of infant drowsiness through milk, and a slightly higher chance of reduced milk supply with regular high-dose use. Neither is absolute, and an occasional single dose is generally acceptable, but for ongoing treatment the non-sedating options are clearly preferred.

Chlorpheniramine (Avil, Cheston, Piriton, and inside Sinarest, D-Cold, Coldarin and similar) is the one you will meet most. Standard dose is 4 mg every 4 to 6 hours, RID around 1 to 5 percent. Even small sedating doses can blunt a baby's alertness and feeding cues, and infant drowsiness, fussiness and reduced feeding have been documented with regular maternal use. One tablet for an acute itch is fine; daily use for weeks is not.

Diphenhydramine (Benadryl, in some cough syrups and an anti-allergy injection) is more sedating and has more documented milk-supply effect. A single dose for an acute reaction is acceptable; regular use is not. Note that Benadryl wet-cough syrup contains ammonium chloride and sodium citrate (compatible), while the dry-cough version contains diphenhydramine and dextromethorphan, so check the label.

Hydroxyzine (Atarax, Hydroxin) is often prescribed for chronic hives and itch; the AAP rates it usually compatible for brief use but cautions on regular use. For severe hives not controlled by non-sedating drugs, the lowest effective dose before the longest sleep stretch is a reasonable compromise, though high-dose cetirizine or levocetirizine is usually preferable.

Promethazine (Phenergan, Avomine) is the most sedating and the most concerning; the AAP previously flagged it as a drug of concern in lactation because of reports of infant apnoea and sedation. Avoid it while breastfeeding; if truly unavoidable, a single dose is unlikely to harm, but regular use is not recommended.

There is one situation where an older antihistamine may still be preferred: an acute itchy allergic reaction needing fast relief, where an intramuscular dose (chlorpheniramine 10 mg or hydroxyzine 25 mg) at a clinic acts within 30 to 60 minutes. For full-blown anaphylaxis, the first-line treatment is intramuscular adrenaline (auto-injector, roughly 5,000 to 8,000 rupees), not antihistamines, and adrenaline is fully compatible with breastfeeding.

The over-the-counter combination cold-and-allergy tablets (Sinarest, D-Cold Total, Coldarin, Cheston Cold, Vicks Action 500) almost all bundle a first-generation antihistamine with paracetamol and a decongestant. They are workable for a one-off cold-with-allergy day but are the wrong choice for ongoing management. A non-sedating antihistamine plus saline plus a steroid nasal spray, with paracetamol added only if you have actual pain or fever, gives better control with far less drug reaching the baby. If your problem is mainly a cold rather than allergy, see the dedicated guide to cold medicine while breastfeeding; the same single-ingredient logic applies to antibiotics while breastfeeding if an infection is involved.

Oral decongestants are bundled into many Indian allergy and cold products and create the single most concerning issue for breastfeeding mothers: a measurable drop in milk supply.

Pseudoephedrine (in Sinarest, D-Cold Total, Cheston Cold, Sudafed, Solvin Cold, Wikoryl) is technically compatible from a milk-transfer view, but the evidence shows a single 60 mg dose can cut milk supply by roughly 20 to 30 percent for the rest of that day, and repeated use can suppress supply for several days. In the supply-establishment phase (the first 6 to 12 weeks) or if your supply is already marginal, avoid it. If you have abundant supply and a strong feeding pattern and genuinely need it once, a single dose with awareness of the effect is acceptable; for more than one dose, choose an alternative.

Phenylephrine (the other oral decongestant in many Indian cold tablets) seems to have a smaller supply effect, but oral phenylephrine is also barely more effective than placebo for a blocked nose, so the benefit is small. It is acceptable for occasional use but is not a useful regular allergy treatment.

Oxymetazoline / xylometazoline sprays (adult Nasivion, adult Otrivin; 100 to 250 rupees) act locally with minimal absorption and are compatible for short-term use up to 3 to 5 days, which is also the maximum to avoid rebound congestion (rhinitis medicamentosa). Use them for an acute block before a flight or to sleep on a bad night, then switch to a steroid spray for ongoing control.

Caffeine (in D-Cold Total, Action 500) transfers to milk with an RID around 6 to 10 percent. One or two cups of chai or coffee a day is usually fine, but caffeine-containing cold tablets stack on top of your usual intake and can quickly make the baby fussy, jittery and hard to settle, especially under 3 months.

The core combination-product problem is that one Indian tablet often crams in paracetamol plus phenylephrine plus chlorpheniramine plus caffeine, exposing the baby to all of them at once. The same symptom coverage usually comes from a smaller, smarter set: a non-sedating antihistamine plus saline plus a steroid nasal spray covers most allergy without any chlorpheniramine, phenylephrine or caffeine the body does not need.

If a combination product is your only option (travelling, or the pharmacy lacks the single-ingredient alternatives), read the label, look up each ingredient in LactMed or e-Lactancia, take it right after a feed to maximise the gap before the next, use it only for the acute episode, and watch the baby for unusual sleepiness or fussiness. Combination products are the default in Indian pharmacies partly out of habit and partly because they carry higher margins; the single-ingredient version is almost always in stock even when not on display. A polite, firm "do you have plain loratadine 10 mg, not the combination" usually produces exactly the right product.

Beyond antihistamines and nasal sprays, several other allergy medicines may be needed during breastfeeding, particularly for asthma, severe hives or stubborn rhinitis. Most are compatible.

Montelukast (Montair, Montek, Romilast, Telekast, Lukotas) is a leukotriene receptor antagonist used for asthma and allergic rhinitis, often added on to an antihistamine or nasal spray. Standard dose is 10 mg in the evening; it is highly protein-bound with limited milk transfer and is rated compatible by LactMed and e-Lactancia, around 100 to 300 rupees a strip. The FDA boxed warning about mood changes, insomnia and vivid dreams is a maternal consideration, not a breastfeeding-specific one.

Cromolyn / sodium cromoglicate (Rynacrom nasal spray, Cromal eye drops) is a mast-cell stabiliser that is barely absorbed, with an excellent breastfeeding profile, but needs four doses a day and is weaker than steroid sprays. It is a reasonable ultra-conservative choice in the very early newborn period; most mothers find the stronger options easier.

Allergy eye drops for itchy, watering eyes are all essentially unabsorbed and compatible: olopatadine (Patanol, Olopat), ketotifen (Asthafen, Zaditor), azelastine (Azep), epinastine (Relestat) and sodium cromoglicate (Cromal), usually one or two drops once or twice daily. Short courses of mild steroid drops (fluorometholone, loteprednol) under an ophthalmologist are also compatible for more severe allergic conjunctivitis.

Asthma inhalers used in India (Pulmicort/budesonide, Flohale/fluticasone, Beclate, Seroflo, Foracort, Asthalin/salbutamol, Levolin) are all compatible with breastfeeding. Inhaled drugs have minimal systemic absorption, and good asthma control is essential; under-treated maternal asthma is far more dangerous than any inhaler. Brief courses of oral prednisolone for a flare are compatible too.

Biologics for severe disease are large molecules with negligible milk transfer. Omalizumab (Xolair) for severe allergic asthma or refractory chronic hives, and dupilumab (Dupixent) for severe eczema or asthma, are generally considered compatible, though the standard advice is to confirm with the prescriber. Allergen immunotherapy (allergy shots or sublingual) is usually continued through breastfeeding if started before pregnancy and well tolerated, but new courses are typically deferred; this is a specialist decision.

Here is a quick reference to common Indian pharmacy allergy products and their breastfeeding status. Formulations change over time, so always check the label of the box you actually buy.

Different allergy presentations call for different strategies. Here is how to handle the common ones faced by Indian breastfeeding mothers.

Seasonal allergic rhinitis (north India spring tree pollen, monsoon mould, regional variation): start a non-sedating antihistamine (loratadine 10 mg or fexofenadine 120 mg) plus a steroid nasal spray about a week before your usual peak season and continue through it, because the spray's controller effect builds over 1 to 2 weeks. Add saline rinses twice daily and eye drops as needed. Avoid going out at peak pollen hours (early morning, evening), keep windows closed, and shower and change clothes after outdoor exposure to wash off pollen.

Perennial allergic rhinitis (year-round dust mites, indoor mould, cockroach allergen, pet dander): daily non-sedating antihistamine plus daily steroid nasal spray, supported by environmental control. Dust-mite-proof mattress and pillow covers (1,500 to 4,000 rupees), weekly hot-water washing of bedding, indoor humidity kept to 40 to 50 percent, a bedroom HEPA filter (Coway, Mi, Honeywell; 8,000 to 30,000 rupees), and removing carpets where practical all help.

Pet allergy: keep the pet out of the bedroom, bathe it weekly, wash your hands after contact and run a HEPA filter, but medication (same as perennial rhinitis) is usually still needed. Pregnancy-related immune shifts can worsen pet allergy in the early postpartum and often ease over the first year; re-homing a beloved pet is rarely necessary with good management.

Food allergy in the mother: most adult food allergies (peanut, tree nut, shellfish, fish, milk, soy, wheat, sesame, egg) are managed by avoiding the food, not by medication, and you should keep breastfeeding through your own food allergy. Only a small amount of allergen passes into milk, and most babies do not react. If your baby has signs of food allergy that improve when you cut a specific food, the usual culprit is cow's-milk protein; learn to tell colic, reflux and cow-milk-protein allergy apart and read about common baby allergies in India and the difference between milk allergy and lactose intolerance before starting any elimination diet, which should be guided so it does not compromise your breastfeeding nutrition.

Eczema (atopic dermatitis) in the mother often flares postpartum from hormones, broken sleep and constant hand-washing. Frequent emollients, short courses of an appropriately potent topical steroid, and topical calcineurin inhibitors (tacrolimus, pimecrolimus) for sensitive areas are all compatible; apply after a feed and keep fresh medicated skin away from the baby. The same skin-care logic that helps your baby's skin is covered in baby eczema and atopic dermatitis.

Hives (urticaria): non-sedating antihistamines at standard dose, increased up to fourfold if needed (this is standard in international urticaria guidelines and is compatible with breastfeeding). If high-dose antihistamines fail, omalizumab is the compatible next step. Short courses of oral steroids for severe flares are fine; avoid known triggers.

Anaphylaxis history: carry an adrenaline auto-injector at all times, use it at the first sign of a serious systemic reaction without waiting, then go straight to an emergency department because the reaction can return as the adrenaline wears off. Adrenaline, and any IV steroids or antihistamines the hospital gives, are all compatible with continued breastfeeding.

For most allergy medicines, no baby effects appear and no special monitoring is needed. Still, knowing what to look for is part of confident, evidence-based use rather than blanket avoidance.

The commonest possible effect of a sedating antihistamine (chlorpheniramine, diphenhydramine, hydroxyzine, promethazine) is mild drowsiness in the baby: unusually sleepy, hard to rouse for feeds, taking shorter feeds, generally less alert. It is dose-dependent and more likely with regular use. If you see this, switch to a non-sedating drug and it should resolve within 1 to 2 days.

The next concern is reduced milk supply, showing up as a fussier, unsatisfied baby, fewer than 6 wet nappies in 24 hours in an exclusively breastfed baby over a week old, or slower weight gain. If this follows a sedating antihistamine or an oral decongestant, switch the drug and add extra pumping to rebuild supply; the broader playbook is in the guide to low milk supply.

Pseudoephedrine specifically tends to drop supply within 24 to 48 hours, often recovering 2 to 3 days after stopping. Caffeine in combination products can make a baby (especially under 3 months) fussy, jittery and hard to settle; switch to caffeine-free options and trim your own chai and coffee for a few days. Knowing how broken sleep and tension also feed into this is covered in stress and breastfeeding.

Steroid nasal sprays, non-sedating antihistamines at standard dose, inhalers and eye drops essentially never cause measurable baby effects, so no special monitoring is needed beyond your normal watching. Brief courses of oral prednisolone (40 to 60 mg for 3 to 7 days) are also fine; only at very high doses (above 80 mg) do some sources suggest waiting 4 hours before feeding.

If the baby reacts unexpectedly (persistent fussiness, rash, vomiting, unusual behaviour) starting around a new medicine, stop that medicine, switch to a clearly safer alternative, watch over 1 to 3 days, and talk to your pediatrician. A LactMed search of the specific drug, or an IBCLC consultation (the ILCA-India directory lists certified consultants; fees are typically 1,500 to 4,000 rupees, with phone and video options), can help interpret the picture and choose alternatives.

The key rule: any baby effect from maternal allergy medicine is reversible by changing the drug. Stopping breastfeeding is essentially never required to manage it. The common Indian advice to stop feeding the moment a baby symptom appears alongside a maternal medicine is not evidence-based and should be filtered through current LactMed and IBCLC guidance, the same way it is for COVID and breastfeeding.

Self-management with over-the-counter allergy medicines works well for most mothers with seasonal or perennial rhinitis, mild hives or mild eczema. See a specialist when:

• LactMed (Drugs and Lactation Database), NIH/NCBI — antihistamines, decongestants, intranasal corticosteroids
• e-Lactancia — breastfeeding compatibility database (loratadine, cetirizine, fluticasone, pseudoephedrine)
• Academy of Breastfeeding Medicine (ABM) Clinical Protocols
• ARIA: Allergic Rhinitis and its Impact on Asthma — international management guidelines
• British Society for Allergy & Clinical Immunology (BSACI) rhinitis guideline
• Indian Academy of Pediatrics (IAP) — Infant and Young Child Feeding guidance
• World Health Organization — Breastfeeding recommendations